Season 1, Episode 5

Discover groundbreaking advancements in CAR T-cell therapy enhancing remission durability for pediatric leukemia. Delve into the genomic factors linked to breast implant-associated lymphomas. Learn about alarming new findings that connect arterial thrombotic events in patients with myeloproliferative neoplasms to an increased risk of developing a second cancer. This insightful discussion highlights the latest in cancer treatment and risk assessments.